This company listing is no longer active
CloudMD Software & Services Inkomsten in het verleden
Verleden criteriumcontroles 0/6
CloudMD Software & Services's earnings have been declining at an average annual rate of -52.4%, while the Healthcare industry saw earnings growing at 17.6% annually. Revenues have been growing at an average rate of 47.8% per year.
Belangrijke informatie
-52.4%
Groei van de winst
-32.1%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | -6.7% |
| Inkomstengroei | 47.8% |
| Rendement op eigen vermogen | -259.9% |
| Nettomarge | -81.8% |
| Laatste winstupdate | 31 Mar 2024 |
Recente prestatie-updates uit het verleden
Recent updates
CloudMD Software & Services Inc. (CVE:DOC) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
Mar 08
CloudMD Software & Services Inc.'s (CVE:DOC) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Oct 21Is CloudMD Software & Services (CVE:DOC) Weighed On By Its Debt Load?
Jan 12Is Now The Time To Look At Buying CloudMD Software & Services Inc. (CVE:DOC)?
Aug 09CloudMD Software & Services Inc.'s (CVE:DOC) Intrinsic Value Is Potentially 39% Above Its Share Price
Jun 20Is CloudMD Software & Services (CVE:DOC) Using Debt In A Risky Way?
May 04Is CloudMD Software & Services (CVE:DOC) A Risky Investment?
Jan 20Opbrengsten en kosten
Hoe CloudMD Software & Services geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 91 | -74 | 38 | 1 |
| 31 Dec 23 | 91 | -77 | 39 | 2 |
| 30 Sep 23 | 91 | -24 | 38 | 2 |
| 30 Jun 23 | 92 | -108 | 40 | 2 |
| 31 Mar 23 | 95 | -114 | 42 | 3 |
| 31 Dec 22 | 99 | -112 | 44 | 4 |
| 30 Sep 22 | 105 | -112 | 45 | 3 |
| 30 Jun 22 | 111 | -28 | 45 | 3 |
| 31 Mar 22 | 89 | -23 | 38 | 2 |
| 31 Dec 21 | 70 | -24 | 32 | 2 |
| 30 Sep 21 | 48 | -23 | 27 | 2 |
| 30 Jun 21 | 22 | -21 | 19 | 2 |
| 31 Mar 21 | 21 | -17 | 17 | 2 |
| 31 Dec 20 | 15 | -14 | 13 | 2 |
| 30 Sep 20 | 12 | -8 | 9 | 2 |
| 30 Jun 20 | 10 | -7 | 7 | 2 |
| 31 Mar 20 | 9 | -5 | 6 | 1 |
| 31 Dec 19 | 7 | -5 | 6 | 1 |
| 30 Sep 19 | 5 | -5 | 6 | 0 |
| 30 Jun 19 | 3 | -5 | 5 | 0 |
| 31 Mar 19 | 2 | -4 | 4 | 0 |
| 31 Dec 18 | 1 | -3 | 2 | 0 |
| 30 Sep 18 | 0 | -1 | 1 | 0 |
| 30 Jun 18 | 0 | -1 | 0 | 0 |
| 31 Mar 18 | 0 | -1 | 0 | 0 |
| 31 Dec 17 | 0 | 0 | 0 | 0 |
| 30 Sep 17 | 0 | 0 | 0 | 0 |
| 30 Jun 17 | 0 | 0 | 0 | 0 |
| 31 Mar 17 | 0 | -2 | 0 | 0 |
| 31 Dec 16 | 0 | -2 | 0 | 0 |
| 30 Sep 16 | 0 | -2 | 0 | 0 |
| 30 Jun 16 | 0 | -2 | 0 | 0 |
| 31 Mar 16 | 0 | 0 | 0 | 0 |
| 31 Dec 15 | 0 | 0 | 0 | 0 |
Kwaliteitswinsten: DOC is currently unprofitable.
Groeiende winstmarge: DOC is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: DOC is unprofitable, and losses have increased over the past 5 years at a rate of 52.4% per year.
Versnelling van de groei: Unable to compare DOC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: DOC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.3%).
Rendement op eigen vermogen
Hoge ROE: DOC has a negative Return on Equity (-259.91%), as it is currently unprofitable.